Fetal stem cells offer hope for babies with brittle bones
NCT ID NCT03706482
First seen Sep 30, 2025 · Last updated Jun 16, 2026 · Updated 35 times
Summary
This study tests a treatment using donated fetal stem cells given through an IV to infants with a severe form of osteogenesis imperfecta (brittle bone disease). The goal is to see if it is safe and can reduce fractures and improve bone strength. Some babies may receive the cells before birth as well as after. The study involves 18 participants and compares them to untreated patients from the past.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOGENESIS IMPERFECTA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Karolinska University Hospital
Stockholm, Stockholm County, 171 76, Sweden
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.